Elanco Animal Health, Inc. (ELAN)
22.76
+0.11
(+0.49%)
USD |
NYSE |
Dec 30, 16:00
22.38
-0.38
(-1.67%)
Pre-Market: 20:00
Elanco Animal Health Research and Development Expense (Quarterly): 89.00M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Zoetis, Inc. | 170.00M |
| Eli Lilly & Co. | 3.466B |
| Merck & Co., Inc. | 3.552B |
| IDEXX Laboratories, Inc. | 63.42M |
| Ligand Pharmaceuticals, Inc. | 21.02M |